Studies that linked ACE2 polymorphisms with diabetes mellitus, stroke and hypertension, either singly or together [10–13], specifically in Asian populations [40,43], partially explain the higher risk of COVID-19-related severity. This evidence concerns the gene ACE2 and COVID-19.